Comparing Implantable Gestrinone and Oral Dienogest for Endometriosis Treatment
Official title: Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis: Randomized Controlled Clinical Trial
Run by Bio Meds Pharmaceutica Ltda · NCT06543550 · Data updated 2026-11-12
This study is testing whether an implantable form of Gestrinone works better than the oral medication Dienogest for relieving endometriosis symptoms in women aged 18 to 45.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 70 (estimated) |
| Sponsor | Bio Meds Pharmaceutica Ltda Industry-sponsored |
| Locations | 4 sites (Campina Grande, Paraíba and 3 other locations) |
| Status | Recruiting |
| Started | July 30, 2024 |
| Main results expected | March 2027 |
| Study ends | March 2028 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT06543550 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult women aged 18 to 45 with a diagnosis of Grade 1 or 2 endometriosis seeking treatment.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have certain hormonal or medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of implantable Gestrinone versus oral Dienogest in alleviating symptoms of endometriosis in adult women. A total of 70 pre-menopausal women aged 18 to 45 will be recruited from private medical clinics across four cities in Brazil. Participants will be randomly assigned to receive either the implantable treatment or the oral medication, with follow-up assessments scheduled at various intervals to monitor pain severity, bleeding levels, and overall quality of life. Data will be analyzed using validated statistical methods to determine the comparative efficacy of the two treatments.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for women suffering from endometriosis.
How similar studies have gone: Other studies have shown promise in using hormonal treatments for endometriosis, but the specific comparison of implantable Gestrinone to oral Dienogest is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult female patients of menstrual age, pre-menopause (18 to 45 years old), who seek medical treatment to alleviate complaints related to endometriosis, who are not undergoing other therapies to treat them. * Patients must have a diagnosis of Grade 1 or 2 endometriosis assessed by imaging tests (ultrasound with bowel preparation and/or MRI of the pelvis with bowel preparation)14, have a BMI of up to 25kg/m2, and weigh between 50 and 70kg. Exclusion Criteria: * Pregnant patients (supporting test must be presented) * Breastfeeding women, using other hormonal contraceptive methods or copper or silver IUDs, who have polycystic ovaries, and/or hyperandrogenism. * Patients using medications that may interfere with androgen metabolism within 4 weeks of screening or during the study. * Patients with a history of liver disease, cardiovascular disease (myocardial infarction, unstable angina or heart failure), active hepatitis, liver neoplasia or renal failure * Patient who are scheduled for surgical treatment during the study period.
Where it's running
-
Instituto Longevite Servicos Medicos LTDA
Campina Grande, Paraíba, Brazil Recruiting -
Nutrindo Ideiais Rio de Janeiro
Rio de Janeiro, Rio de Janeiro, Brazil Recruiting -
Jpml Clinica Medica LTDA
São José dos Campos, São Paulo, Brazil Recruiting -
Nutrindo Ideiais São Paulo
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Study coordinator: André V. A. Florentino, Dr
- Email: f.andrevinicius@gmail.com
- Phone: +55 83 982001868
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.